Off-label drugs vs. the merits of centralised regulatory control
| Year of publication: |
2008
|
|---|---|
| Authors: | Boscheck, Ralf |
| Published in: |
Intereconomics. - Heidelberg : Springer, ISSN 0020-5346. - Vol. 43.2008, 5, p. 277-281
|
| Publisher: |
Heidelberg : Springer |
| Subject: | Arzneimittelrecht | Verbraucherschutz | Pharmazeutisches Produkt | Deregulierung | Gesundheitswesen | USA | Deutschland |
-
Off-label drugs vs. the merits of centralised regulatory control
Boscheck, Ralf, (2008)
-
Psychopharmakologisches Enhancement zwischen Konsumentensouveränität und Verbraucherschutz
Schlag, Stefan, (2013)
-
Michaeli, Daniel, (2024)
- More ...
-
COVID-19 and the political economy of shared adjustment
Boscheck, Ralf, (2021)
-
Market drive and governance : re-examining the rules for economic and commercial contest
Boscheck, Ralf, (2002)
-
Intellectual property rights and the evergreening of pharmaceuticals
Boscheck, Ralf, (2015)
- More ...